drugset / Trial / NCT02595437
Triferic Pediatric Pharmacokinetic Protocol
NaSingle-groupOpen-labelTreatment
Summary
The main purpose is to determine the pharmacokinetics (PK) of Triferic iron administered intravenously in pediatric patients with chronic kidney disease on chronic hemodialysis (CKD-5HD). It is an open-label, two-period sequential dosing study.
Timeline
- Start
- 2015-11-01
- Primary completion
- 2016-12
- Completion
- 2017-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Triferic | Other / unclassified | 0.07 mg/kg | Intravenous |